Delivery Order SPE2DR25D3306-SPE2DR26F5F0G
- Not listed
- The Defense Logistics Agency awarded a $2,654.35 delivery order to AmerisourceBergen Drug Corp for ProQuad vials on November 13, 2025, with a completion date of December 5, 2025. This firm fixed-price order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The contract was competitively awarded with no set-aside designation. ProQuad is a combination vaccine...
- The Defense Logistics Agency awarded a $3,341.80 delivery order to AmerisourceBergen Drug Corp for ProQuad vials on June 20, 2025, with an ultimate completion date of July 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $1,654.33 firm fixed price delivery order to AmerisourceBergen Drug Corp for ProQuad vials on August 20, 2025, with a completion date of September 11, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million and extending through December 2026. The order will be performed at AmerisourceBergen's corporate headquarters in...
- The Defense Logistics Agency awarded a delivery order valued at $26,020.20 to AmerisourceBergen Drug Corp for ProQuad vials on November 13, 2025, with an ultimate completion date of December 5, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999. The contract was competitively awarded with no set-aside designation and will be...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,696.30 to AmerisourceBergen Drug Corp for ProQuad vials on September 19, 2025, with an ultimate completion date of October 10, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ProQuad vials valued at $2,740.40 with an ultimate completion date of August 19, 2025. This firm fixed price, competitively awarded delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $6,055.26 to AmerisourceBergen Drug Corp for ProQuad vials on August 5, 2025, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is located in...
- The Defense Logistics Agency awarded a delivery order valued at $2,713.46 to AmerisourceBergen Drug Corp for ProQuad vials on September 15, 2025, with a completion date of October 6, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.999 billion through December 2026. ProQuad is a combination vaccine used for...
- The Defense Logistics Agency awarded a delivery order valued at $10,617.48 to AmerisourceBergen Drug Corp for ProQuad vials on November 5, 2025, with completion targeted for November 28, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,602.02 to AmerisourceBergen Drug Corp for ProQuad vials on November 4, 2025, with a completion date of November 26, 2025. This non-competitive, firm fixed-price delivery order is being performed at the contractor's Conshohocken, Pennsylvania facility and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA. ProQuad is a combination vaccine used for immunization against measles, mumps,...
- SPE2DR25D3306Indefinite Delivery Contract
- SPE2DR25D3306-SPE2DR26F5F0GDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,654.35 to AmerisourceBergen Drug Corp for ProQuad vials on December 1, 2025, with an ultimate completion date of December 22, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. ProQuad is a combination vaccine used for immunization against measles, mumps, rubella, and varicella, making this delivery order part of DLA's critical pharmaceutical and medical supply procurement for military healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a prime vendor for federal medical procurement and demonstrates extensive capability in fulfilling vaccine and pharmaceutical needs across the Defense Health Agency and other government healthcare systems. This delivery order exemplifies the company's role in supporting military readiness through the supply of essential medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 11/30/25 |